Last updated October 21, 2026. Approval line checked October 21, 2026. No compounding source date is assigned.
FDA status
Approved
Approved. Triptorelin is the active ingredient in FDA-approved products such as Trelstar, for specific indications. Approval is specific to the product, indication, and route.
Drugs@FDA: Trelstar (NDA 020715)By signing up you agree to get PeptideX update emails. Unsubscribe anytime. Educational only, not medical advice.
Evidence tier
Human RCT. The tier is the highest indexed study type. It is not a safety rating and it is not an FDA approval. Confidence score 5/5. 2,448 PubMed citations indexed.
Triptorelin (D-Trp6-LHRH) is a synthetic GnRH decapeptide agonist that initially causes a transient LH/FSH surge but, with continuous or depot administration, causes receptor desensitization and downr
What the literature studies
Metabolic Research
Evidence tier
Human RCT
Compounding record
Status not verified
Status not verified. No product-specific FDA primary source is recorded for this entry. FDA approval and compounding eligibility are not verified. Research information is not evidence of FDA approval. Approval, where applicable, is specific to a drug product, indication and route. Research information is not evidence of FDA approval. Approval, where applicable, is specific to a drug product, indication and route.
Regulatory source not verified; no checked date is assigned.
The testosterone flare at initiation can cause bone pain crisis, ureteral obstruction, or spinal cord compression in patients with advanced prostate metastases; co-administration o
By signing up you agree to get PeptideX update emails. Unsubscribe anytime. Educational only, not medical advice.
Educational only. Not medical advice. This page does not give doses or sourcing. See the medical and editorial disclaimer.